glp 1 agonist review article Only a few week old (2026 jan 22) systematic revealed that GLP-1 agonists have the greatest benefit for younger non-diabetic female patients. https://diabetesjournals.org/care/article /48/2/292/157724/Efficacy-of-GLP-1-Receptor-Agonists-on-Weight Table 1 from Glucagon-Like Peptide-1

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

[Google Scholar] 195.Nauck M.A

Precision Metabolic Medicine: Selecting the Right Next-Gen Treatment The question is no longer if these new GLP-1 drugs work, but which one is optimized for a given patients complex biology

27 Effective management combines patient education, gradual dose escalation, and nonpharmacologic strategies

During my 16 years of publishing HealthNewsReview.org, we drilled this theme into our readers over and over and over

Obesity As described above, overweight and obesity are far too prevalent, with roughly 75% of U.S